We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GOOG:NASDAQAlphabet Inc. Analysis

Data as of 2026-05-19 - not real-time

$384.90

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Alphabet’s stock is trading at $384.90, comfortably above its 20‑day ($375.79), 50‑day ($334.26) and 200‑day ($293.23) simple moving averages, signaling a continued bullish momentum. The RSI of 62 reinforces strength while the MACD histogram shows a modest bearish divergence, and a decreasing volume trend adds a note of caution. With a beta of 1.27 and a 30‑day volatility of 36.7%, the share exhibits higher market sensitivity, yet the Fear & Greed Index at 89.18 (Extreme Greed) reflects strong investor optimism. Fundamentally, revenue grew 21.8% YoY to $422.5 B, gross margin sits at 60.4% and operating margin at 36.1%, delivering an ROE of 38.9% and a low payout ratio of 6.4%, underscoring cash‑flow robustness. The DCF fair‑value estimate of $74.83 suggests the market is pricing significant growth premium, and the upside/downside metric of +9.6% aligns with analyst median targets around $427.5. Recent material news – Mizuho’s upgraded price target to $460, Jim Cramer’s bullish commentary, a $190 B capex boost and Google Cloud’s $20 B revenue (up 63%) – further support a positive outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Price above key moving averages
  • RSI indicating strength but approaching overbought
  • Decreasing volume and bearish MACD histogram

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust 21.8% revenue growth and high margins
  • Analyst target median $427.5 and upside potential
  • Strong cash position and low dividend payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Accelerating AI and cloud revenue (Google Cloud +63%)
  • High ROE (38.9%) and sustainable free cash flow
  • Strategic investments and favorable analyst sentiment

Key Metrics & Analysis

Financial Health

Revenue Growth21.80%
Profit Margin37.92%
P/E Ratio29.4
ROE38.88%
ROA14.64%
Debt/Equity20.03
P/B Ratio9.7
Op. Cash Flow$174.4B
Free Cash Flow$27.9B
Industry P/E17.1

Technical Analysis

TrendBullish
RSI62.3
Support$332.96
Resistance$404.47
MA 20$375.79
MA 50$334.26
MA 200$293.23
MACDBearish
VolumeDecreasing
Fear & Greed Index89.18

Valuation

Fair Value$74.83
Target Price$421.69
Upside/Downside9.56%
GradeOvervalued
TypeGrowth
Dividend Yield0.22%

Risk Assessment

Beta1.27
Volatility36.74%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.